☆ 4.4 Review

Chronic Myeloid Leukemia: Clinical Impact of BCR-ABL1 Mutations and Other Lesions Associated With Disease Progression

SEMINARS IN ONCOLOGY (2012)

Get Full Text
Add to Collection

Journal

SEMINARS IN ONCOLOGY
Volume 39, Issue 1, Pages 58-66

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.seminoncol.2011.11.002

Keywords

-

Categories

Oncology

Funding

  1. Novartis
  2. Bristol-Myers Squibb

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.